Introduction Stenotrophomonas maltophilia is acquiring increasing importance as a nosocomial pathogen. Methods We retrospectively studied the characteristics and outcome …
HS Chung, SG Hong, YR Kim, KS Shin… - Journal of Korean …, 2013 - synapse.koreamed.org
The aim of this study was to determine antimicrobial susceptibility of recent clinical Stenotrophomonas maltophilia isolates from Korea, and to compare the activity levels of …
YT Tekçe, A Erbay, H Cabadak, S Şen - Journal of chemotherapy, 2012 - Taylor & Francis
Abstract Trimethoprim-sulfamethoxazole (TMP-SMZ) is recommended as the treatment of choice for Stenotrophomonas maltophilia infections. However, when the administration of …
K Dalhoff, M Abele-Horn, S Andreas, T Bauer… - …, 2012 - thieme-connect.com
Die nosokomiale Pneumonie ist eine häufige Komplikation von Krankenhausaufenthalten. Die meisten Daten liegen zur beatmungsassoziierten Pneumonie vor, aber auch auf …
ML Townsend, MW Pound, RH Drew - Infection and drug …, 2011 - Taylor & Francis
Tigecycline is a member of the glycylcycline class of antimicrobials, which is structurally similar to the tetracycline class. It demonstrates potent in vitro activity against causative …
AJ Brink, D Bizos, KD Boffard, C Feldman… - SAMJ: South African …, 2010 - scielo.org.za
BRINK, AJ et al. Guideline: appropriate use of tigecycline. SAMJ, S. Afr. med. j.[online]. 2010, vol. 100, n. 6, pp. 388-394. ISSN 2078-5135. INTRODUCTION: Tigecycline, the first of a new …
D KARAMANLIOĞLU, M Dizbay - Turkish Journal of Medical …, 2019 - journals.tubitak.gov.tr
Background/aim: The aim of this study was to determine the usefulness of tigecycline in combination treatment of Stenotrophomonas maltophilia infections by evaluating the in vitro …